Cite
MLA Citation
K.A. Papp et al.. “Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody3.” British journal of dermatology, vol. 180, 2019, pp. 1352–1360. http://access.bl.uk/ark:/81055/vdc_100086230896.0x000062